Companies/Biovica International AB
Follow

Biovica International AB

Nasdaq First North GM Stockholm (Sweden)

Biovica is a biotech company which develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 4
View all
www.biovica.com
Current instruments
Type
Ticker
ISIN
SHARE
BIOVIC B
SE0008613731
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
BIOVIC B
SE0008613731
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Biovica International AB with ticker BIOVIC B
Status
Active
Currency
SEK
Segment
First North Premier
First trading date
29 Mar 2017
Private placement
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
People
Anders Rylander
CEO
Lars Holmqvist
Chairman of the board
Maria Holmlund
Board member
Ulf Jungnelius
Board member
Henrik Osvald
Board member
Jesper Söderqvist
Board member
Anders Rylander
Board member
Annika Berg
Board member
Marie-Louise Fjällskog
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Dag Hammarskjölds väg 54 B
Zip code
752 37
City/district
Uppsala
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556774-6150
LEI code
549300VADE1VRR555N78
First trade date
29 Mar 2017
Registration date
03 Jan 2009
Short name
BIOVIC

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More